SILAC quantitative proteomics analysis of ivermectin‐related proteomic profiling and molecular network alterations in human ovarian cancer cells-Reference-Cited by-同舟云学术

SILAC quantitative proteomics analysis of ivermectin‐related proteomic profiling and molecular network alterations in human ovarian cancer cells

Published:2020-10-12 Issue:1 Volume:56 Page:
ISSN:1076-5174
Container-title:Journal of Mass Spectrometry
language:en
Short-container-title:J Mass Spectrom

Author:

Li Na¹²³,Li Jiajia¹²³,Desiderio Dominic M.⁴,Zhan Xianquan¹²³⁵⁶^ORCID

Affiliation:

1. University Creative Research Initiatives Center Shandong First Medical University 6699 Qingdao Road Jinan Shandong 250117 China

2. Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital Central South University 87 Xiangya Road Changsha Hunan 410008 China

3. State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital Central South University 87 Xiangya Road Changsha Hunan 410008 China

4. The Charles B. Stout Neuroscience Mass Spectrometry Laboratory, Department of Neurology, College of Medicine University of Tennessee Health Science Center Memphis Tennessee 38163 USA

5. Department of Oncology, Xiangya Hospital Central South University 87 Xiangya Road Changsha Hunan 410008 China

6. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University 87 Xiangya Road Changsha Hunan 410008 China

Publisher

Wiley

Subject

Spectroscopy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jms.4659

Reference48 articles.

1. Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation

2. Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations

3. Ivermectin – Old Drug, New Tricks?